/Investor DB

HOF Capital — 2017 Investments

2 investments dated 2017 · listed companies and verified rows first · show all

Recursion Pharmaceuticalsrecursion.comin𝕏NASDAQ: RXRXSeries B · Oct 2017 · $60M

Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.

AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US

Chris Gibson(Co-founder and Chairman of the Board)inBlake C. Borgeson(Executive Officer, Director)inDean Y. Yi(Executive Officer, Director)Najat Khan(Chief Executive Officer)inNajat Khan, Ph.D.(CEO and President)inBlake Borgeson(Founder)

Co-investorsDCVC (Data Collective)Lux CapitalBaillie GiffordAdvantage Capital PartnersAmplify PartnersCatalio Capital Management, LP+22 more

BenRevobenrevo.comSeed · Jul 2017 · $2M

BenRevo is a US company that provides an online platform for transacting health insurance products.

InsurTechSan Diego, US

Jimson TharayilOjas SitaparaJason Char(Executive Officer, Director)

Co-investors500 GlobalSilicon Badia

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.